A functional polymorphism in the succinate-semialdehyde dehydrogenase (aldehyde dehydrogenase 5 family, member A1) gene is associated with cognitive ability

Molecular Psychiatry

Volumn 9, Issue 6, 2004, Pages 582-586

  Plomin, R ^a   Turic, D M ^b   Hill, L ^a   Turic, D E ^b   Stephens, M ^b   Williams, J ^b   Owen, M J ^b   O'Donovan, M C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cognition; Functional polymorphism; Intelligence; QTL; Succinate semialdehyde dehydrogenase (SSADH)

Indexed keywords

SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ALLELE; ARTICLE; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FAMILY; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; INTELLIGENCE QUOTIENT; PARENT; PRIORITY JOURNAL; PROGENY; SEQUENCE ANALYSIS;

ALDEHYDE OXIDOREDUCTASES; COGNITION; DNA; EXONS; GENOTYPE; HUMANS; INTELLIGENCE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE; WECHSLER SCALES;

EID: 3042740807     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001441     Document Type: Article

References (38)

1. Plomin R. Genetics and general cognitive ability. Nature 1999; 402: C25-C29.
2. Plomin R. Genetics, genes, genomics and g. Mol Psychiatry 2003; 8: 1-5.
3. Payton A, Holland F, Diggle P, Rabbitt P, Horan M, Davidson Y et al. Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. Mol Psychiatry 2003; 8: 14-18.
4. Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, Macmurray JP. Role of the cholinergic muscarinic 2 receptor [CHRM2] gene in cognition. Mol Psychiatry 2003; 8: 10-11.
5. Malhotra AK, Kestler LJ, Mazzani C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159: 652-654.
6. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
7. Blasi P, Boyl PP, Ledda M, Novelletto A, Gibson KM, Jakobs C et al. Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms. Mol Genet Metab 2002; 76: 348-362.
8. Chambliss KL, Hinson DD, Trettel F, Malaspina P, Novelletto A, Jakobs C et al. Two exon-skipping mutations as the molecular basis of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria). Am J Hum Genet 1998; 63: 399-408.
9. Gibson KM, Hoffmann GF, Hodson AK, Bottiglieri T, Jakobs C. 4-Hydroxybutyric acid and the clinical phenotype of Succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 1998; 29: 14-20.
10. Turic D, Langley K, Mills S, Stephens M, Lawson D, Govan C et al. Follow-up of genetic linkage findings on chromosome 16p13:evidence of association of N-methyl-Daspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry 2004; 9: 170-174.
11. Plomin R, Hill L, Craig IW, McGuffin P, Purcell S, Sham P et al. A genome-wide scan of 1842 DNA markers for allelic associations with general cognitive ability: a five-stage design using DNA pooling. Behav Genet 2001; 31: 497-509.
12. Lubinski D, Benbow CP. The first three decades of a planned 50-year study of intellectual talent. In: Subotnik R, Arnold K (eds). Beyond Terman: Longitudinal Studies in Contemporary Gifted Education. Ablex: Norwood, NJ, 1994 pp 255-281.
13. Lubinski D, Webb RM, Morelock MJ, Benbow CP. Top 1 in 10 000: a 10-year follow-up of the profoundly gifted. J Appl Psychol 2001; 86: 718-729.
14. Flynn J. Searching for justice: the discovery of IQ gains over time. Am Psychol 1999; 54: 5-20.
15. Wechsler D. Wechsler Intelligence Scale for Children - Revised. The Psychological Corporation: New York, 1974.
16. Wechsler D. Wechsler Adult Intelligence Scale-III. New York: The Psychological Corporation, 1997.
17. Freeman B, Powell J, Ball DM, Hill L, Craig IW, Plomin R. DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet 1997; 27: 251-257.
18. Austin J, Hoogendoorn B, Buckland P, Speight G, Cardno A, Bowen T et al. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Mol Psychiatry 2003; 5: 208-212.
19. Norton N, Williams NM, Williams HJ, Spurlock G, Kirov G, Morris DW et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA Pools. Hum Genet 2002; 110: 471-478.
20. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003; 113: 149-153.
21. Cash CD, Maitre M, Mandel P. Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hyrdoxybutyrate. J Neurochem 1979; 33: 1169-1175.
22. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57: 455-464.
23. Mott DD, Lewis DV. Facilitation of the induction of long-term potentiation by GABAB receptors. Science 1991; 252: 1718-1720.
24. Paulsen O, Moser EL. A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 1998; 21: 273-278.
25. White AM, Platt B. Ionic mechanisms of GABA-induced long-term potentiation in the rat superior colliculus. Exp Brain Res 2001; 140: 486-494.
26. Leung LS, Wu C. Kindling suppresses primed-burst-induced long-term potentiation in hippocampal CAI. NeuroReport 2003; 14: 211-214.
27. A receptors. Neurobiology 2002; 99: 8980-8985.
28. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 2002; 415: 526-530.
29. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
30. Cardon LR, Bell J. Association study designs for complex diseases. Nat Genet 2001; 2: 91-99.
31. Glatt CE, Freimer NB. Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends Genet 2002; 18: 307-312.
32. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
33. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.
34. Plomin R. Genetic research on general cognitive ability as a model for mild mental retardation. Int Rev Psychiatry 1999; 11: 34-36.
35. Plomin R, Spinath FM. Genetics and general cognitive ability (g). Trends Cogn Sci 2002; 6: 169-176.
36. Thompson PM, Cannon TD, Narr KL, van Erp T, Poutanen VP, Huttunen M et al. Genetic influences on brain structure. Nat Neurosci 2001; 4: 1253-1258.
37. Gray JR, Chabris CF, Braver TD. Neural mechanisms of general fluid intelligence. Nat Neurosci 2003; 6: 316-322.
38. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.